Citation

Chorvat RJ, Berbaum J, Seriacki K, McElroy JF.: JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities. Bioorg Med Chem Lett, Volume 22 (19), 2012

Authors

Berbaum J, Chorvat RJ, McElroy JF., Seriacki K

Journal

Bioorg Med Chem Lett

Year

2012

DOI

10.1016/j.bmcl.2012.08.004

PubMed

22959249

Machine-readable

REST APIRDF